PTPN23

Chr 3

protein tyrosine phosphatase non-receptor type 23

Also known as: HD-PTP, HDPTP, NEDBASS, PTP-TD14

This gene encodes a member of the non-receptor type protein-tyrosine phosphatase family. The encoded protein may be involved in the regulation of small nuclear ribonucleo protein assembly and pre-mRNA splicing by modifying the survival motor neuron (SMN) complex. The encoded protein additionally plays a role in ciliogenesis and is part of endosomal sorting complex required for transport (ESCRT) pathways. This gene may serve a tumor suppressor function. [provided by RefSeq, Jul 2016]

GeneReviewsResearchGenerating clinical summary…
LOFmechanismLOEUF 0.37
Clinical SummaryPTPN23
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.25) despite low pLI — interpret in context.
📋
ClinVar Variants
54 unique Pathogenic / Likely Pathogenic· 740 VUS of 1611 total submissions
📖
GeneReview available — PTPN23
Authoritative clinical overview · Recommended first read
Open GeneReview ↗
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.37LOEUF
pLI 0.031
Z-score 5.88
OE 0.25 (0.170.37)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
1.33Z-score
OE missense 0.88 (0.830.93)
872 obs / 989.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.25 (0.170.37)
00.351.4
Missense OE?0.88 (0.830.93)
00.61.4
Synonymous OE?1.11
01.21.6
LoF obs/exp: 18 / 71.7Missense obs/exp: 872 / 989.8Syn Z: -1.75
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePTPN23-related neurodevelopmental disorder with or without structural brain anomalies, optic atrophy, seizures and spasticityLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6162th %ile
GOF
0.6247th %ile
LOF
0.3065th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

1611 submitted variants in ClinVar

Classification Summary

Pathogenic34
Likely Pathogenic20
VUS740
Likely Benign716
Benign42
Conflicting36
34
Pathogenic
20
Likely Pathogenic
740
VUS
716
Likely Benign
42
Benign
36
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
31
2
1
0
34
Likely Pathogenic
18
2
0
0
20
VUS
20
685
33
2
740
Likely Benign
0
13
227
476
716
Benign
0
11
17
14
42
Conflicting
36
Total697132784921,588

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

7 pathogenic / likely-pathogenic (of 13) ClinVar copy-number / structural variants overlap PTPN23 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PTPN23 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →